On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats.
作者信息
Carta Manolo, Cenci M Angela
机构信息
Department of Biomedical Sciences, Section of Physiology, Cagliari University, Cagliari, Italy.
Basal Ganglia Pathophysiology, Department of Experimental Medical Science, Lund University, Lund, Sweden.
出版信息
Mov Disord. 2016 Jan;31(1):149. doi: 10.1002/mds.26519. Epub 2016 Jan 8.
PMID:26749366
Abstract
摘要
相似文献
1
On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats.
Mov Disord. 2016 Jan;31(1):149. doi: 10.1002/mds.26519. Epub 2016 Jan 8.
2
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.左旋多巴诱导运动障碍动物模型中埃托啡嗪抗运动障碍作用的研究。
Mov Disord. 2013 Jul;28(8):1088-96. doi: 10.1002/mds.25366. Epub 2013 Feb 6.
3
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity.依替唑仑通过降低纹状体谷氨酸和直接通路活性预防左旋多巴诱导的运动障碍。
Mov Disord. 2015 Nov;30(13):1728-38. doi: 10.1002/mds.26326. Epub 2015 Jul 24.
4
Possible role for chlorpheniramine in the treatment of L-DOPA induced dyskinesia in Parkinson's disease.氯苯那敏在帕金森病左旋多巴诱导的异动症治疗中的潜在作用。
Pharm World Sci. 2008 Jan;30(1):1-2. doi: 10.1007/s11096-007-9138-7. Epub 2007 Jun 28.
5
Eltoprazine modulated gamma oscillations on ameliorating L-dopa-induced dyskinesia in rats.依替唑仑通过调节γ 振荡改善左旋多巴诱导的大鼠异动症。
CNS Neurosci Ther. 2023 Oct;29(10):2998-3013. doi: 10.1111/cns.14241. Epub 2023 Apr 30.
6
Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.帕金森病大鼠模型中移植诱导运动障碍的 5-羟色胺能和多巴胺能机制。
Neurobiol Dis. 2012 Sep;47(3):393-406. doi: 10.1016/j.nbd.2012.03.038. Epub 2012 Apr 12.
7
Rating scales for dyskinesias in Parkinson's disease.帕金森病异动症的评定量表。
Mov Disord. 1999;14 Suppl 1:48-53.
8
Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease.利鲁唑用于治疗晚期帕金森病中左旋多巴诱发的异动症。
Lancet. 1999 May 22;353(9166):1764-5. doi: 10.1016/S0140-6736(99)00120-8.
9
Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.血清素5-HT(1A)受体“偏向性激动剂”在帕金森病和左旋多巴诱导的异动症大鼠模型中的活性
Neuropharmacology. 2015 Jun;93:52-67. doi: 10.1016/j.neuropharm.2015.01.012. Epub 2015 Jan 31.
10
L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum.帕金森病大鼠模型中左旋多巴诱导的运动障碍与感觉运动纹状体中去甲肾上腺素的波动释放有关。
J Neurosci Res. 2014 Dec;92(12):1733-45. doi: 10.1002/jnr.23439. Epub 2014 Jun 26.
引用本文的文献
1
Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model.头孢曲松可降低 6-羟多巴胺帕金森病模型中左旋多巴诱导的运动障碍严重程度。
Mov Disord. 2017 Nov;32(11):1547-1556. doi: 10.1002/mds.27077. Epub 2017 Jun 20.
Zotero 插件